title: Bioresorbable vascular scaffold for the treatment of coronary bifurcations: What have we learned?
abstract: Bioresorbable vascular scaffolds (BVS) remain experimental for the treatment of coronary bifurcations (B) and further clinical data is needed before widespread adoption in this setting. Preliminary, clinical outcome in B using a provisional stenting or double stenting approach with BVS is encouraging and close to the one observed with next-generation drug-eluting stent. Improvements in device navigability, reduction in strut bulk and reabsorption time may render the device more predictable and simpler to use.
authors.affiliation: Department of Interventional Cardiology and Endovascular Therapeutics, Instituto Cardiovascular De Buenos Aires, Ciudad Autónoma De Buenos Aires, Argentina.
authors.forename: Jorge A
authors.initials: JA
authors.lastname: Belardi
authors.affiliation: Department of Interventional Cardiology and Endovascular Therapeutics, Instituto Cardiovascular De Buenos Aires, Ciudad Autónoma De Buenos Aires, Argentina.
authors.forename: Mariano
authors.initials: M
authors.lastname: Albertal
mesh_terms: D020341:Absorbable Implants; D015906:Angioplasty, Balloon, Coronary / Q000379:methods*; D023921:Coronary Stenosis / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D015607:Stents